Protara Therapeutics Q1 2026 Earnings EPS Beats Estimates Amid Continued Pipeline Progress CEPU Q4 2024 Earnings Steep EPS Miss Pressures Shares as Argentine Headwinds Intensify PAMT Q2 2025 Earnings Major EPS Miss Weighs on Shares Clipper Realty Inc Q1 2026 Earnings Positive EPS of 005 Highlights Resilient Operations IN8bio Q1 2026 Earnings Narrowed Loss Beats Expectations as Development Pipeline Advances RYM Q3 2022 Earnings Deep Earnings Miss Amid Negative Surprise